Concepedia

Martin Lukačišin

ML

5

Publications

420

Citations

5

H-Index

2012

Active since

Affiliations

Technion – Israel Institute of Technology(Current)

University of Cologne

Institute of Science and Technology Austria

Martin Lukačišin is an author at Technion – Israel Institute of Technology specializing in breast cancer, cell biology, and cell development.

Top concepts

MedicineCell BiologyBreast CancerTumor BiologyCancer BiologyCell DevelopmentTissue DevelopmentCancer Cell BiologyDevelopmental BiologyMammary Gland Development

Publications per year

2012–2024

5

Publications

5

Elf5 inhibits the epithelial–mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2

Rumela Chakrabarti, Julie Hwang, Andrés Blanco et al. · Nature Cell Biology · 2012 · 284 citations · Full text

Breast Cancer Metastasis, Developmental Biology, Tissue Development +10

Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity

Michael Maurer, Goran Rakočević, Carol S. Leung et al. · Journal of Clinical Investigation · 2012 · 69 citations · Full text

Intron-mediated induction of phenotypic heterogeneity

Martin Lukačišin, Adriana Espinosa‐Cantú, Tobias Bollenbach · Nature · 2022 · 29 citations · Full text

Emergent Gene Expression Responses to Drug Combinations Predict Higher-Order Drug Interactions

Martin Lukačišin, Tobias Bollenbach · Cell Systems · 2019 · 24 citations · Full text

Interactions between immune cell types facilitate the evolution of immune traits

Tania Dubovik, Martin Lukačišin, Elina Starosvetsky et al. · Nature · 2024 · 14 citations · Full text

Rows per page

1–5 of 5